Antenatal corticosteroids for fetal lung maturation: an overview of Cochrane reviews
dc.contributor.author | McGoldrick, Emma | |
dc.contributor.author | Brown, Julie | |
dc.contributor.author | Middleton, Philippa | |
dc.contributor.author | McKinlay, Christopher J. D. | |
dc.contributor.author | Haas, David M. | |
dc.contributor.author | Crowther, Caroline A. | |
dc.contributor.department | Department of Obstetrics and Gynecology, IU School of Medicine | en_US |
dc.date.accessioned | 2016-11-15T19:32:32Z | |
dc.date.available | 2016-11-15T19:32:32Z | |
dc.date.issued | 2016 | |
dc.description.abstract | This is the protocol for a review and there is no abstract. The objectives are as follows: The objective is to summarise the available evidence from Cochrane systematic reviews for the effectiveness and safety of antenatal corticosteroid therapy to improve infant outcomes. | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | McGoldrick, E., Brown, J., Middleton, P., McKinlay, C. J., Haas, D. M., & Crowther, C. A. (2016). Antenatal corticosteroids for fetal lung maturation: an overview of Cochrane reviews. In Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd. Retrieved from http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD012156/abstract | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/11459 | |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.isversionof | 10.1002/14651858.CD012156 | en_US |
dc.relation.journal | Cochrane Database of Systematic Reviews | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | Publisher | en_US |
dc.subject | antenatal corticosteroid therapy | en_US |
dc.subject | fetal lung maturation | en_US |
dc.subject | Cochrane reviews | en_US |
dc.title | Antenatal corticosteroids for fetal lung maturation: an overview of Cochrane reviews | en_US |
dc.type | Article | en_US |